Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep and Insulin Resistance: The Impact of Gender Affirming Hormone Therapy in the Adolescent Transgender Population

NCT05489159 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05489159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05489159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep and Insulin Resistance: The Impact of Gender Affirming Hormone Therapy in the Adolescent Transgender Population
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
October 12, 2022
Completion date
August 16, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gender dysphoria, insulin resistance, sleep disorder